Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
CA 2307891 A1 · Owner: Hyun, Byung-Hwa · Inventors: Kim, Young-Kook; Park, Yong-Bok; Kwon, Yong-Kook
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to uses of naringin or naringenin for inhibiting the activity of acyl CoA-cholestrol-o-acyltransferase inhibiting the , accumulation of macrophage-lipid complex on the arterial endothelium and , preventing or treating hepatic diseases in a mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 20, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 20, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 20, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.